These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3245507)

  • 1. Development of Eglin c as a drug: pharmacokinetics.
    Nick HP; Probst A; Schnebli HP
    Adv Exp Med Biol; 1988; 240():83-8. PubMed ID: 3245507
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C.
    Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Bodmer JL; Virca GD; Lucey EC; Stone PG; Snider GL
    Prog Clin Biol Res; 1985; 180():287-90. PubMed ID: 3849804
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
    Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
    Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elastase-inhibitor eglin has no effect in an ovine model of endotoxemia.
    Redl H; Schlag G; Vogl C; Schiesser A; Paul E; Thurnher M; Junger W; Traber LD; Traber DL
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():153-6. PubMed ID: 3060136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte neutral proteinase inhibitor of the pig: modification by eglin C and superoxide dismutase of the response to shock.
    Siebeck M; Hoffmann H; Geiger R; Schweiberer L
    Prog Clin Biol Res; 1989; 308():945-51. PubMed ID: 2675078
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
    Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
    FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis.
    Baici A; Seemüller U
    Biochem J; 1984 Mar; 218(3):829-33. PubMed ID: 6562888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the elastase inhibitor eglin C in porcine endotoxin shock.
    Siebeck M; Hoffmann H; Weipert J; Fritz H
    Circ Shock; 1992 Mar; 36(3):174-9. PubMed ID: 1351797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
    Faller B; Dirrig S; Rabaud M; Bieth JG
    Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conductimetry: a new tool for studying inhibition of elastolysis.
    Saulnier J; Bostancioglu K; Favre-Bonvin G; Wallach J
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():75-8. PubMed ID: 3202974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes.
    Hornebeck W; Soleilhac JM; Tixier JM; Moczar E; Robert L
    Cell Biochem Funct; 1987 Apr; 5(2):113-22. PubMed ID: 3495371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for the ineffectiveness of eglin C to ameliorate endotoxin shock in sheep.
    Junger WG; Lieners C; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():953-7. PubMed ID: 2780742
    [No Abstract]   [Full Text] [Related]  

  • 13. Eglin c, a pharmacologically active elastase inhibitor.
    Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Virca GD; Bodmer JL; Snider GL; Lucey EC; Stone PG
    Eur J Respir Dis Suppl; 1985; 139():66-70. PubMed ID: 3862612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency.
    Dean RT; Nick HP; Schnebli HP
    Biochem Biophys Res Commun; 1989 Mar; 159(2):821-7. PubMed ID: 2784675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the interaction of chymotrypsin with eglin c.
    Faller B; Bieth JG
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):27-32. PubMed ID: 1741752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization of human leukocyte elastase with its inhibitor Pro44-eglin c.
    Heinz DW; Liersch M; Grütter MG
    J Mol Biol; 1989 Jun; 207(3):641-2. PubMed ID: 2760927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the lysosomal elastase inhibitor eglin on the development of interstitial lung edema in E. coli bacteremia in pigs.
    Welter HF; Siebeck M; Thetter O; Jochum M
    Prog Clin Biol Res; 1987; 236A():121-5. PubMed ID: 2441402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
    Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
    Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of varying the time interval between intratracheal administration of eglin-c and human neutrophil elastase on prevention of emphysema and secretory cell metaplasia in hamsters. With observations on the fate of eglin-c and the effect of repeated instillations.
    Lucey EC; Stone PJ; Christensen TG; Breuer R; Calore JD; Snider GL
    Am Rev Respir Dis; 1986 Sep; 134(3):471-5. PubMed ID: 3530070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-[N-acetyl]eglin c:poly(oxyethylene) conjugates: preparation, plasma persistence, and urinary excretion.
    Goddard P; O'Mullane J; Ambler L; Daw A; Brookman L; Lee A; Petrak K
    J Pharm Sci; 1991 Dec; 80(12):1171-6. PubMed ID: 1815077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.